AIM Rule 26 Information

Biome Technologies plc provides the following information to AIM investors in accordance with Rule 26 of the AIM Rules. The information was last updated on 2 January 2025.

• A description of Biome Technologies business is provided here
• The names of Biome Technologies directors and brief biographical details of each are provided here
• As an AIM traded company incorporated in the UK, Biome Technologies plc is subject to the UK City Code on Takeovers and Mergers legislation
• The Company has adopted the Quoted Companies Alliance Corporate Governance Code 2018 and a statement of its compliance is provided here. Details of the terms of reference of the Company’s board committees can be found below:
  • Remuneration committee (PDF)
  • Nomination Committee (PDF)
  • Audit Committee (PDF)
• Biome Technologies plc is incorporated in the UK and this is the main country of operation
• Biome Technologies plc current Articles of Association is provided here
• Details of the nominated adviser and other advisers can be found here
• As of 2 January 2025, the Company has 51,555,814 ordinary shares in issue. So far as the Directors are aware, as of 2 January 2025, approximately 73.35% of the Company’s ordinary shares were not in public hands
• As at 2 January 2025, significant beneficial shareholders holding 3%+ of issued capital are:

*Mr Vivian Pereira’s holding includes ordinary shares held by his wife.

• As at 2 January 2025, Directors holdings of issued capital are:

• The Company’s annual reports can be found here
• The Company’s half yearly reports can be found here
• The Company’s regulatory information service notifications can be found here
• The Company’s prospectus on its 2010 move to AIM can be found here
• The Company’s circulars or similar publications sent to shareholders can be found here
• The Company has not applied or agreed to have its shares traded on any other exchanges or platforms
• The Company does not currently have any shares in treasury
• There are no restrictions on the transfer of the Company’s ordinary shares